Record Multi-System Order
Secured a record multi-system order from a top 20 global biopharma customer, with contributions beginning in Q4 2025 and extending into 2026 and beyond.
Revenue and Growth Metrics
Reported Q3 2025 revenue of $7.8 million, which is a 3% increase compared to Q3 2024, marking the 12th consecutive quarter of meeting or beating revenue guidance.
Consumables Revenue Growth
Consumables revenue, a key demand indicator, increased 40% to a quarterly record, contributing to a 32% increase in recurring revenue year-over-year.
MilliporeSigma Collaboration Advancements
Continued progress with MilliporeSigma, including the development of a global sales funnel and initial product supply agreement aimed at lowering costs and improving margins.